MedStar Diabetes Institute — Washington D.C., District of Columbia

MedStar Diabetes Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MedStar Diabetes Institute has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Diabetes Institute?

MedStar Diabetes Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Diabetes Institute conducted?

MedStar Diabetes Institute has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is MedStar Diabetes Institute accredited by Crixeo Health?

MedStar Diabetes Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Diabetes Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.